EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 348 (2026) EPJ Web Conf., 348 (2026) 01007 References
Open Access
Issue
EPJ Web Conf.
Volume 348, 2026
3rd International Conference on Innovations in Molecular Structure & Instrumental Approaches (ICMSI 2026)
Article Number 01007
Number of page(s) 11
Section Life Science
DOI https://doi.org/10.1051/epjconf/202634801007
Published online 21 January 2026
  1. A.K. Chettupalli, A. Sisodia, S.K. Abdul Rahaman, S.P.N. Bukke, N. Boggula, Phytochemicals in Prevention and Management of Cardiovascular Disease. In: Medicinal Plants and Their Bioactives in Human Diseases. Springer Nature Switzerland, Cham, pp 103–125 (2025). https://doi.org/10.1007/978-3-032-01356-9 5 [Google Scholar]
  2. H. Sun, D. Chen, W. Xin, L. Ren, Q. Li, X. Han, Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy. Front. Pharmacol. 14, 1146651 (2023). https://doi.org/10.3389/fphar.2023.1146651 [Google Scholar]
  3. M. Su, W. Zhao, S. Xu, J. Weng, Resveratrol in treating diabetes and its cardiovascular complications: a review of its mechanisms of action. Antioxidants. 11, 1085 (2022). https://doi.org/10.3390/antiox11061085 [Google Scholar]
  4. G. Wang, X. Song, L. Zhao, Z. Li, B. Liu, Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity. BioMed Res. Int. 2018, 2150218 (2018). https://doi.org/10.1155/2018/2150218 [Google Scholar]
  5. S.J. Hewlings, D.S. Kalman, Curcumin: A review of its effects on human health. Foods. 6, 92 (2017). https://doi.org/10.3390/foods6100092 [Google Scholar]
  6. B.L. Tan, M.E. Norhaizan, Curcumin combination chemotherapy: The implication and efficacy in cancer. Molecules. 24, 2527 (2019). https://doi.org/10.3390/molecules24142527 [Google Scholar]
  7. G. Derosa, P. Maffioli, A.F. Cicero, Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin. Biol. Ther. 12, 1113–1124 (2012). https://doi.org/10.1517/14712598.2012.704014 [Google Scholar]
  8. L. Zhao, Z. Cang, H. Sun, X. Nie, N. Wang, Y. Lu, Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocr. Disord. 17, 13 (2017). https://doi.org/10.1186/s12902-017-0165-7 [Google Scholar]
  9. J. Dawi, S. Affa, E. Gonzalez, Y. Misakyan, D. Nikoghosyan, K. Hajjar, S. Kades, S. Fardeheb, H. Mirzoyan, V. Venketaraman, Ferroptosis in cardiovascular disease and cardiomyopathies: therapeutic implications of glutathione and iron chelating agents. Biomedicines. 12, 558 (2024). https://doi.org/10.3390/biomedicines12030558 [Google Scholar]
  10. B. Chong, J. Jayabaskaran, S.M. Jauhari, S.P. Chan, R. Goh, M.T.W. Kueh, H. Li, Y.H. Chin, G. Kong, V.V. Anand, J.W. Wang, Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur. J. Prev. Cardiol. 32, 1001–1015 (2025). https://doi.org/10.1093/eurjpc/zwae281 [Google Scholar]
  11. C.W. Tsao, A.W. Aday, Z.I. Almarzooq, C.A. Anderson, P. Arora, C.L. Avery, C.M. Baker-Smith, A.Z. Beaton, A.K. Boehme, A.E. Buxton, Y. Commodore-Mensah, Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 147, e93-e621 (2023). https://doi.org/10.1161/CIR.0000000000001123 [Google Scholar]
  12. J. Amengual, Bioactive properties of carotenoids in human health. Nutrients. 11, 2388 (2019). https://doi.org/10.3390/nu11102388 [Google Scholar]
  13. M. Sanchez, M. Romero, M. Gömez-Guzman, J. Tamargo, F. Pérez-Vizcaino, J. Duarte, Cardiovascular effects of flavonoids. Curr. Med. Chem. 26, 6991–7034 (2019). https://doi.org/10.2174/0929867326666181220094721 [Google Scholar]
  14. Z.H. Deng, J. Liao, J.Y. Zhang, X.H. Hao, C. Liang, L.H. Wang, H. Xue, K. Zhang, G.T. Yan, Localized leptin release may be an important mechanism of curcumin action after acute ischemic injuries. J. Trauma Acute Care Surg. 74, 1044–1051 (2013). https://doi.org/10.1097/TA.0b013e3182826eba [Google Scholar]
  15. B.P. George, R. Chandran, H. Abrahamse, Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants. 10, 1455 (2021). https://doi.org/10.3390/antiox10091455 [Google Scholar]
  16. A.S. Choudhari, P.C. Mandave, M. Deshpande, P. Ranjekar, O. Prakash, Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front. Pharmacol. 10, 1614 (2020). https://doi.org/10.3389/fphar.2019.01614 [Google Scholar]
  17. N. Venkatesan, Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 124, 425–427 (1998). https://doi.org/10.1038/si.bip.0701877 [Google Scholar]
  18. S. de Pascual-Teresa, D.A. Moreno, C. Garcia-Viguera, Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int. J. Mol. Sci. 11, 1679–1703 (2010). https://doi.org/10.3390/iims11041679 [Google Scholar]
  19. W. Kong, J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, S. Wang, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10, 1344–1351 (2004). https://doi.org/10.1038/nm1135 [Google Scholar]
  20. F. Zimetti, M.P. Adorni, N. Ronda, R. Gatti, F. Bernini, E. Favari, The natural compound berberine positively affects macrophage functions involved in atherogenesis. Nutr. Metab. Cardiovasc. Dis. 25, 195–201 (2015). https://doi.org/10.1016/i.numecd.2014.08.004 [Google Scholar]
  21. M. Xiao, L.N. Men, M.G. Xu, G.B. Wang, H.T. Lv, C. Liu, Berberine protects endothelial progenitor cell from damage of TNF-a via the PI3K/AKT/eNOS signaling pathway. Eur. J. Pharmacol. 743, 11–16 (2014). https://doi.org/10.1016/i.eiphar.2014.09.024 [Google Scholar]
  22. A. Ranian, S. Ramachandran, N. Gupta, I. Kaushik, S. Wright, S. Srivastava, H. Das, S. Srivastava, S. Prasad, S.K. Srivastava, Role of phytochemicals in cancer prevention. Int. J. Mol. Sci. 20, 4981 (2019). https://doi.org/10.3390/iims20204981 [Google Scholar]
  23. I. Jaswir, D. Noviendri, R.F. Hasrini, F. Octavianti, Carotenoids: Sources, medicinal properties and their application in food and nutraceutical industry. J. Med. Plants Res. 5, 7119–7131 (2011). https://doi.org/10.5897/JMPRx11.011 [Google Scholar]
  24. J. Lako, V.C. Trenerry, M. Wahlqvist, N. Wattanapenpaiboon, S. Sotheeswaran, R. Premier, Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fiiian fruit, vegetables and other readily available foods. Food Chem. 101, 1727–1741 (2007). https://doi.org/10.1016/i.foodchem.2006.01.031 [Google Scholar]
  25. C. Sumbilla, D. Lewis, T. Hammerschmidt, G. Inesi, The slippage of the Ca2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. J. Biol. Chem. 277, 13900–13906 (2002). https://doi.org/10.1074/ibc.M111155200 [Google Scholar]
  26. T. Morimoto, Y. Sunagawa, T. Kawamura, T. Takaya, H. Wada, A. Nagasawa, M. Komeda, M. Fuiita, A. Shimatsu, T. Kita, K. Hasegawa, The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118, 868–878 (2008). https://doi.org/10.1172/JCI33160 [Google Scholar]
  27. B.B. Aggarwal, K.B. Harikumar, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41, 40–59 (2009). https://doi.org/10.1016/j.biocel.2008.06.010 [Google Scholar]
  28. P.G. Pietta, Flavonoids as antioxidants. J. Nat. Prod. 63, 1035–1042 (2000). https://doi.org/10.1021/np9904509 [Google Scholar]
  29. S. Tyagi, G. Singh, A. Sharma, G. Aggarwal, Phytochemicals as candidate therapeutics: An overview. Int. J. Pharm. Sci. Rev. Res. 3, 53–55 (2010). [Google Scholar]
  30. P.I. Oteiza, A.G. Erlejman, S.V. Verstraeten, C.L. Keen, C.G. Fraga, Flavonoid-membrane interactions: A protective role of flavonoids at the membrane surface?. J. Immunol. Res. 12, 19–25 (2005). https://doi.org/10.1080/10446670410001722168 [Google Scholar]
  31. M. Hesari, P. Mohammadi, F. Khademi, D. Shackebaei, S. Momtaz, N. Moasefi, M.H. Farzaei, M. Abdollahi, Current advances in the use of nanophytomedicine therapies for human cardiovascular diseases. Int. J. Nanomedicine. 16, 3293–3315 (2021). https://doi.org/10.2147/IJN.S295508 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.